These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 29995488)

  • 1. Long-Acting Reversible Contraception: A Silver Bullet Solution for Unintended Pregnancy?
    Thomas A; Karpilow QC
    Am J Public Health; 2018 Aug; 108(8):1007-1008. PubMed ID: 29995488
    [No Abstract]   [Full Text] [Related]  

  • 2. Long-acting reversible contraception: an important solution to reduce unintended pregnancy.
    Nelson AL; Kaunitz AM
    Am J Obstet Gynecol; 2017 May; 216(5):539. PubMed ID: 28284931
    [No Abstract]   [Full Text] [Related]  

  • 3. Not seeking yet trying long-acting reversible contraception: a 24-month randomized trial on continuation, unintended pregnancy and satisfaction.
    Hubacher D; Spector H; Monteith C; Chen PL
    Contraception; 2018 Jun; 97(6):524-532. PubMed ID: 29470950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reply to 'Response to Current barriers and potential strategies to increase the use of long-acting reversible contraception (LARC) to reduce the rate of unintended pregnancies in Australia: An expert roundtable discussion'.
    Bateson D; Mazza D; Frearson M; Goldstone P; Kovacs G; Baber R
    Aust N Z J Obstet Gynaecol; 2017 Dec; 57(6):E16-E17. PubMed ID: 29210049
    [No Abstract]   [Full Text] [Related]  

  • 5. Meeting the Contraceptive Needs of a Community: Increasing Access to Long-Acting Reversible Contraception.
    McNicholas C; Madden T
    Mo Med; 2017; 114(3):163-167. PubMed ID: 30228573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-Acting Reversible Contraceptives: An Important Approach to Reduce Unintended Pregnancies.
    Vieira CS
    Rev Bras Ginecol Obstet; 2016 May; 38(5):207-9. PubMed ID: 27213515
    [No Abstract]   [Full Text] [Related]  

  • 7. Unintended pregnancy and subsequent postpartum long-acting reversible contraceptive use in Zimbabwe.
    Nance N; Ralph L; Padian N; Cowan F; Buzdugan R; Mushavi A; Mahomva A; McCoy SI
    BMC Womens Health; 2018 Nov; 18(1):193. PubMed ID: 30477497
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quality of websites about long-acting reversible contraception: a descriptive cross-sectional study.
    Eriksson C; Skinstad M; Georgsson S; Carlsson T
    Reprod Health; 2019 Nov; 16(1):172. PubMed ID: 31775765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In response to: Current barriers and potential strategies to increase the use of long-acting reversible contraception to reduce the rate of unintended pregnancies in Australia: An expert roundtable discussion.
    Turner JV
    Aust N Z J Obstet Gynaecol; 2017 Dec; 57(6):E15-E16. PubMed ID: 29210050
    [No Abstract]   [Full Text] [Related]  

  • 10. Long-acting reversible contraceptive acceptability and unintended pregnancy among women presenting for short-acting methods: a randomized patient preference trial.
    Hubacher D; Spector H; Monteith C; Chen PL; Hart C
    Am J Obstet Gynecol; 2017 Feb; 216(2):101-109. PubMed ID: 27662799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost Minimization Analysis of Same-Day Long-Acting Reversible Contraception for Adolescents.
    Wilkinson TA; Downs SM; Tucker Edmonds B
    JAMA Netw Open; 2019 Sep; 2(9):e1911063. PubMed ID: 31509208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention of unintended pregnancy: a focus on long-acting reversible contraception.
    Pickle S; Wu J; Burbank-Schmitt E
    Prim Care; 2014 Jun; 41(2):239-60. PubMed ID: 24830607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increasing Use of Long-Acting Reversible Contraception to Decrease Unplanned Pregnancy.
    Lotke PS
    Obstet Gynecol Clin North Am; 2015 Dec; 42(4):557-67. PubMed ID: 26598299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost of unintended pregnancy in Sweden - a possibility to lower costs by increasing LARC usage.
    Engstrand S; Kopp Kallner H
    Contraception; 2018 May; 97(5):445-450. PubMed ID: 29409858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Knowledge of and concerns about long-acting reversible contraception among women in medication-assisted treatment for opioid use disorder.
    Matusiewicz AK; Melbostad HS; Heil SH
    Contraception; 2017 Nov; 96(5):365-369. PubMed ID: 28778423
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Review of Long-Acting Reversible Contraception Methods and Barriers to Their Use.
    Baron MM; Potter B; Schrager S
    WMJ; 2018 Oct; 117(4):156-159. PubMed ID: 30407765
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrating Pregnancy Ambivalence and Effectiveness in Contraceptive Choice.
    Sundstrom B; Ferrara M; DeMaria AL; Baker-Whitcomb A; Payne JB
    Health Commun; 2017 Jul; 32(7):820-827. PubMed ID: 27420543
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is Long-Acting Reversible Contraceptive Use Increasing? Assessing Trends Among U.S. College Women, 2008-2013.
    Logan RG; Thompson EL; Vamos CA; Griner SB; Vázquez-Otero C; Daley EM
    Matern Child Health J; 2018 Nov; 22(11):1639-1646. PubMed ID: 29936659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Are Health Plan Design and Prior Use of Long-Acting Reversible Contraception Associated with Pregnancy Intention?
    Armstrong MA; Postlethwaite DA; Darbinian JA; McCoy M; Law A
    J Womens Health (Larchmt); 2017 May; 26(5):450-460. PubMed ID: 27753522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Public-Private Partnership to Reduce Unintended Pregnancy Rates and Improve Economic Mobility.
    Plescia M; Garmon-Brown O
    N C Med J; 2016; 77(6):389-390. PubMed ID: 27864485
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.